BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10961828)

  • 1. Financial managers' costing expertise is needed in clinical trials.
    West DA; Balas EA; West TD
    J Health Care Finance; 2000; 27(1):11-20. PubMed ID: 10961828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Product line cost estimation: a standard cost approach.
    Cooper JC; Suver JD
    Healthc Financ Manage; 1988 Apr; 42(4):60, 62, 64 passim. PubMed ID: 10286385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three financial strategies.
    West DA
    J Health Care Finance; 2003; 30(1):10-22. PubMed ID: 12967240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials finance and operations.
    O'Brien JA
    J Med Pract Manage; 2007; 22(6):369-71. PubMed ID: 17612316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The principles of quality-associated costing: derivation from clinical transfusion practice.
    Trenchard PM; Dixon R
    Qual Manag Health Care; 1997; 5(4):43-52. PubMed ID: 10169784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applying activity-based costing to healthcare settings.
    Canby JB
    Healthc Financ Manage; 1995 Feb; 49(2):50-2, 54-6. PubMed ID: 10146178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced ABC costing for hospitals: directed expense costing.
    Ryan J
    Hosp Cost Manag Account; 1997 Oct; 9(7):5-8. PubMed ID: 10173184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicare reimbursement for clinical trial services: understanding Medicare coverage in establishing a clinical trial budget.
    Barnes M; Korn J
    J Health Law; 2005; 38(4):609-31. PubMed ID: 16673632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and analysis issues for economic analysis alongside clinical trials.
    Marshall DA; Hux M
    Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New model helps find missing link between financial and clinical health care management.
    Dasso E; Wilson T
    Physician Exec; 2001; 27(6):51-6. PubMed ID: 11769167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developing a decision support system to meet nurse managers' information needs for effective resource management.
    Ruland CM
    Comput Nurs; 2001; 19(5):187-93. PubMed ID: 11577660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tip of the iceberg: financial liability analysis and clinical trials.
    Baio KT; Takamoto R
    Healthc Financ Manage; 2006 Jun; 60(6):102-4, 106, 108. PubMed ID: 16773995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using cost accounting data to improve clinical value.
    Andrianos J; Dykan M
    Healthc Financ Manage; 1996 May; 50(5):44-8. PubMed ID: 10157016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity-based costing and its application in a Turkish university hospital.
    Yereli AN
    AORN J; 2009 Mar; 89(3):573-6, 579-91. PubMed ID: 19269382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trend reports a tool for efficiently managing materials.
    Spring T
    Healthc Financ Manage; 1989 Oct; 43(10):54-8, 60, 62. PubMed ID: 10294622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conducting a cost-effectiveness trial in oncology: justification and method].
    Lejeune C; Binquet C; Bonnetain F
    Bull Cancer; 2009 May; 96(5):603-7. PubMed ID: 19435689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costing and perspective in published cost-effectiveness analysis.
    Neumann PJ
    Med Care; 2009 Jul; 47(7 Suppl 1):S28-32. PubMed ID: 19536023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making or losing money with participation in clinical trials: a decision analysis.
    Jacobs VR
    Onkologie; 2009 Jul; 32(7):411-6. PubMed ID: 19556819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis.
    Evans WK; Coyle D; Gafni A; Walker H;
    Chronic Dis Can; 2003; 24(4):102-7. PubMed ID: 14733759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.